Table 1 Description of the clinical-pathological characteristics of the cohort of Ovarian Cancer patients (M&M for details on categories reported)
From: BRCA germline mutation test for all woman with ovarian cancer?
Histology | N (%) |
|---|---|
Serous Epithelial | 1312 (59,8) |
Mucinous | 143 (6,5) |
Endometrioid | 322 (14,7) |
Clear Cell | 201 (9,2) |
Mixed | 98 (4,5) |
Other Epithelial (Brunner) | 79 (3,6) |
Undifferentiatied | 5 (0,2) |
N/A | 32 (1,3) |
Disease Stage FIGO | |
1 | 523 (23,9) |
2 | 249 (11,4) |
3 | 1103 (50,3) |
4 | 25 (1,1) |
N/A | 292 (13,3) |
Grade Differentiation | |
Well | 447 (20,4) |
Moderately | 261 (11,9) |
Poorly | 1255 (57,2) |
Undifferentiated | 15 (0,7) |
N/A | 214 (9,8) |
Ovarian Cancer family History | |
No | 1718 (78,4) |
Yes | 107 (4,9) |
N/A | 367 (16,7) |
Breast Cancer Family History | |
No | 1519 (69,2) |
Yes | 319 (14,5) |
N/A | 354 (16,1) |
BRCA1/2 alterations | |
Present | 182 (8,4) |
Absent | 2010 (91,6) |